Home
Resources
Diseases
COVID-19
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hexavalent vaccines
HPV vaccines
Malaria vaccines
PCV vaccines
RSV vaccines
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
Belgium
Type of publications
NITAG documentation (85)
Countries
Belgium (85)
Afghanistan (1)
Algeria (1)
Angola (1)
Argentina (30)
Armenia (2)
Australia (110)
Bahrain (3)
Bangladesh (6)
Benin (6)
Bhutan (1)
Bolivia (3)
Brazil (10)
Burkina Faso (16)
Burundi (1)
Cameroon (3)
Canada (142)
Central African Republic (1)
Chad (4)
Chile (67)
China (62)
Colombia (1)
Comoros (1)
Congo (Democratic Republic of) (1)
Costa Rica (1)
Côte d’Ivoire (17)
Denmark (3)
Ethiopia (36)
Finland (1)
France (177)
Germany (73)
Ghana (2)
Greece (1)
Guinea (1)
Honduras (14)
India (31)
Indonesia (6)
Ireland (26)
Islamic Republic of Iran (12)
Israel (2)
Italy (18)
Japan (3)
Jordan (1)
Kazakhstan (2)
Kenya (5)
Kyrgyzstan (5)
Lebanon (1)
Lesotho (1)
Liberia (1)
Luxembourg (31)
Madagascar (1)
Malawi (1)
Malaysia (1)
Maldives (1)
Mali (3)
Malta (1)
Mexico (2)
Mongolia (1)
Morocco (1)
Mozambique (42)
Myanmar (1)
Nepal (9)
Netherlands (51)
New Zealand (10)
Nicaragua (1)
Niger (5)
Nigeria (15)
North Korea (1)
Norway (1)
Oman (6)
Pakistan (4)
Peru (2)
Romania (1)
Russian Federation (1)
Saudi Arabia (10)
Senegal (10)
Serbia (1)
Sierra Leone (1)
Slovenia (7)
Somalia (1)
South Africa (13)
South Korea (8)
South Sudan (1)
Spain (30)
Sri Lanka (4)
Sudan (2)
Sweden (22)
Switzerland (19)
Tanzania (United Republic Of) (4)
Thailand (10)
Timor-Leste (1)
Togo (1)
Tunisia (1)
Turkey (1)
Uganda (28)
Ukraine (1)
United Arab Emirates (1)
United Kingdom (127)
United States of America (478)
Uruguay (2)
Zambia (3)
Show more
Diseases
Chikungunya (2)
COVID-19 (22)
Dengue (1)
Diphtheria (1)
Hepatitis A (1)
Hepatitis B (1)
Herpes zoster (1)
Human papillomavirus (HPV) (3)
Influenza (19)
Measles (1)
Meningococcal disease (3)
Mpox (3)
Pneumococcal disease (9)
Poliomyelitis (1)
Rabies (1)
Rotavirus (2)
RSV (Respiratory syncytial virus) (2)
Rubella (1)
Smallpox (1)
Tick-borne encephalitis (1)
Varicella (2)
Yellow fever (1)
Show more
85 results found
2021
Booster vaccination against COVID-19
2021
∙
Conseil Supérieur de la Santé (CSS)
Co-administration of COVID-19 vaccines with other vaccines (simultaneous vaccination)
2021
∙
Conseil Supérieur de la Santé (CSS)
CSS Recommendations for vaccination against SARS-CoV-2 in pregnant women, women wishing to become pregnant or breastfeeding using a messenger RNA vaccine - 15 April, 2021
2021
Mandatory vaccination of healthcare personnel
2021
∙
Conseil Supérieur de la Santé (CSS)
Non-replicating viral vector vaccines and the Belgian COVID-19 vaccination strategy
2021
∙
Conseil Supérieur de la Santé (CSS)
Prioritization of at-risk groups for SARS-CoV-2 Vaccination (Phase 1b)
2021
∙
Conseil Supérieur de la Santé (CSS)
Recommendations for the administration of one or two doses of mRNA vaccines in people who are or have been infected with SARS-CoV-2 in Belgium - 09 June 2021
2021
∙
Conseil Supérieur de la Santé (CSS)
Recommendations for the vaccination of children at increased risk of invasive pneumococcal disease (PID)
2021
∙
Conseil Supérieur de la Santé (CSS)
Recommendations regarding the pediatric vaccination against SARS-CoV-2 of children aged older than 12 in Belgium
2021
∙
Conseil Supérieur de la Santé (CSS)
Recommendations regarding the pediatric vaccination against SARS-CoV-2 of children aged older than 12 in Belgium - 9 July 2021
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register
